Healthcare Providers and Services
Company Overview of The Cleveland Clinic Foundation
The Cleveland Clinic Foundation is a medical practice group that provides clinical and hospital care, research, and educational services. The group treats different illness and disorders including anesthesia, brain tumor, cancer, cardiovascular, arthritis, blood, diabetes, infertility, kidney, skin, rehabilitation, hernia, central nervous system, endocrinology, and genetics. It was founded in 1921 and is based in Cleveland, Ohio.
9500 Euclid Avenue
Cleveland, OH 44195
Founded in 1921
Key Executives for The Cleveland Clinic Foundation
Chief Financial Officer and Treasurer
Chief Executive Officer of Cleveland Clinic Regional Hospitals
Chief Executive Officer of Cleveland Clinic Abu Dhabi
Compensation as of Fiscal Year 2014.
The Cleveland Clinic Foundation Key Developments
Cleveland Clinic Announces Board Appointments
Jun 16 14
Cleveland Clinic has elected a new member to its Board of Directors and five new members to its Board of Trustees in 2014, representing the areas of real estate, manufacturing, restaurant management, private equity, building and property management, civic boards, and the arts. Ronald E. Weinberg, director and principal of the Weinberg Capital Group was elected to the 21-member Board of Directors June 2. The newly elected trustees are: Sam Covelli, president of Covelli Enterprises, was elected Feb. 3, 2014. Jeffrey I. Friedman, chairman, president and CEO of Associated Estates Realty Corporation, was elected Feb. 3, 2014. Harley Gross, a partner at Gross Builders, was elected Feb. 3, 2014. Gross currently chairs Cleveland Clinic's Taussig Cancer Institute Leadership Board. Debbie A. Crawford, former McKinsey and Company consultant and executive director of Red, was elected April 7, 2014. Anthony A. 'Tony' Petrarca, president of Cedarwood Development Inc. and chairman of Tri-C Construction Company Inc., was elected April 7, 2014.
Synergetics USA Announces Cooperative Agreement to Develop Next Generation Intraoperative Devices
May 12 14
Synergetics USA, Inc. announced the completion of a cooperative development agreement with Cleveland Clinic to develop next generation intraoperative devices. These devices are expected to lead to improved visualization of surgical sites leading to more precise tissue targeting and improved surgical outcomes. The agreement calls for Synergetics to provide research and development resources for the collaborative development of specific devices designed for the purpose of significantly advancing the nature of vitreoretinal surgery as it is performed May 12, 2014.
Genzyme Announces Multi-Year Multiple Sclerosis Research Collaboration with Cleveland Clinic
Apr 30 14
Genzyme announced the formation of a research collaboration with Cleveland Clinic focused on developing new therapeutic approaches to the treatment of MS. This innovative collaboration aligns the research efforts of both organizations around projects which are designed to develop a deep understanding of the pathogenesis and progression of MS and to address the unmet medical needs in MS, particularly progressive forms of the disease. Initially the collaboration will focus on projects that explore strategies to address neurodegeneration, a hallmark of progressive MS, and novel technologies to better understand the pathology of the disease. The collaboration will be led by a joint steering committee comprised of Genzyme and Cleveland Clinic researchers and span a minimum of 5 years.
Similar Private Companies By Industry
Recent Private Companies Transactions